Transcriptomic analyses revealed a significant deregulation of multiple metabolic pathways in chronic phase CML LSCs when compared with normal HSCs, suggesting BCR::ABL1-mediated metabolic reprogramming in the early phase of leukemogenesis. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.